Use of serum C-reactive protein as an early marker of inflammatory activity in canine type II immune-mediated polyarthritis: case report

BACKGROUND: Monitoring systemic inflammatory activity during steroid therapy of canine immune-mediated polyarthritis (IMPA) is difficult and mainly relies on clinical signs. CASE PRESENTATION: Canine serum C-reactive protein (CRP) was measured serially and blinded during a 27-week follow-up period o...

Descripción completa

Detalles Bibliográficos
Autores principales: Kjelgaard-Hansen, Mads, Jensen, Asger Lundorff, Houser, Geoffrey A, Jessen, Lisbeth Rem, Kristensen, Annemarie T
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1553462/
https://www.ncbi.nlm.nih.gov/pubmed/16987405
http://dx.doi.org/10.1186/1751-0147-48-9
_version_ 1782129352064892928
author Kjelgaard-Hansen, Mads
Jensen, Asger Lundorff
Houser, Geoffrey A
Jessen, Lisbeth Rem
Kristensen, Annemarie T
author_facet Kjelgaard-Hansen, Mads
Jensen, Asger Lundorff
Houser, Geoffrey A
Jessen, Lisbeth Rem
Kristensen, Annemarie T
author_sort Kjelgaard-Hansen, Mads
collection PubMed
description BACKGROUND: Monitoring systemic inflammatory activity during steroid therapy of canine immune-mediated polyarthritis (IMPA) is difficult and mainly relies on clinical signs. CASE PRESENTATION: Canine serum C-reactive protein (CRP) was measured serially and blinded during a 27-week follow-up period of a case of Anaplasma phagocytophilia induced type II immune-mediated polyarthritis. CONCLUSION: WBC was, as expected, observed not to reflect the inflammatory activity during steroid treatment in a clinical useful manner, whereas, CRP is suggested a valuable unbiased marker of inflammatory activity during steroid treatment in this case.
format Text
id pubmed-1553462
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-15534622006-08-25 Use of serum C-reactive protein as an early marker of inflammatory activity in canine type II immune-mediated polyarthritis: case report Kjelgaard-Hansen, Mads Jensen, Asger Lundorff Houser, Geoffrey A Jessen, Lisbeth Rem Kristensen, Annemarie T Acta Vet Scand Case Report BACKGROUND: Monitoring systemic inflammatory activity during steroid therapy of canine immune-mediated polyarthritis (IMPA) is difficult and mainly relies on clinical signs. CASE PRESENTATION: Canine serum C-reactive protein (CRP) was measured serially and blinded during a 27-week follow-up period of a case of Anaplasma phagocytophilia induced type II immune-mediated polyarthritis. CONCLUSION: WBC was, as expected, observed not to reflect the inflammatory activity during steroid treatment in a clinical useful manner, whereas, CRP is suggested a valuable unbiased marker of inflammatory activity during steroid treatment in this case. BioMed Central 2006-06-21 /pmc/articles/PMC1553462/ /pubmed/16987405 http://dx.doi.org/10.1186/1751-0147-48-9 Text en Copyright © 2006 Kjelgaard-Hansen et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Kjelgaard-Hansen, Mads
Jensen, Asger Lundorff
Houser, Geoffrey A
Jessen, Lisbeth Rem
Kristensen, Annemarie T
Use of serum C-reactive protein as an early marker of inflammatory activity in canine type II immune-mediated polyarthritis: case report
title Use of serum C-reactive protein as an early marker of inflammatory activity in canine type II immune-mediated polyarthritis: case report
title_full Use of serum C-reactive protein as an early marker of inflammatory activity in canine type II immune-mediated polyarthritis: case report
title_fullStr Use of serum C-reactive protein as an early marker of inflammatory activity in canine type II immune-mediated polyarthritis: case report
title_full_unstemmed Use of serum C-reactive protein as an early marker of inflammatory activity in canine type II immune-mediated polyarthritis: case report
title_short Use of serum C-reactive protein as an early marker of inflammatory activity in canine type II immune-mediated polyarthritis: case report
title_sort use of serum c-reactive protein as an early marker of inflammatory activity in canine type ii immune-mediated polyarthritis: case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1553462/
https://www.ncbi.nlm.nih.gov/pubmed/16987405
http://dx.doi.org/10.1186/1751-0147-48-9
work_keys_str_mv AT kjelgaardhansenmads useofserumcreactiveproteinasanearlymarkerofinflammatoryactivityincaninetypeiiimmunemediatedpolyarthritiscasereport
AT jensenasgerlundorff useofserumcreactiveproteinasanearlymarkerofinflammatoryactivityincaninetypeiiimmunemediatedpolyarthritiscasereport
AT housergeoffreya useofserumcreactiveproteinasanearlymarkerofinflammatoryactivityincaninetypeiiimmunemediatedpolyarthritiscasereport
AT jessenlisbethrem useofserumcreactiveproteinasanearlymarkerofinflammatoryactivityincaninetypeiiimmunemediatedpolyarthritiscasereport
AT kristensenannemariet useofserumcreactiveproteinasanearlymarkerofinflammatoryactivityincaninetypeiiimmunemediatedpolyarthritiscasereport

Ejemplares similares